Lysophospholipids: two-faced mediators in atherosclerosis

By Bot Martine   Nofer Jerzy-Roch   van Berkel Theo JC   Biessen Erik AL  

Future Lipidology, Vol. 2, Iss. 3, 2007-06 ,pp. : 341-356

Future Medicine

Access to resources Recommend Favorite

Characterization of two whey protein genes in the Australian dasyurid marsupial, the stripe-faced dunnart (Sminthopsis macroura)

By  

Cytogenetic and Genome Research, Vol. 115, Iss. 1, 2006-09 ,pp. : 62-69

Karger

Access to resources Recommend Favorite

A comparison of the resources used in advanced cancer care between two different strong opioids: an analysis of naturalistic practice in the UK

By Guest Julian F.   Ruiz Francis J.   Russ Jo   Gupta Roben Das   Mihai Adela   Greener Mark  

Current Medical Research and Opinion, Vol. 21, Iss. 2, 2005-02 ,pp. : 271-280

Informa Healthcare

Access to resources Recommend Favorite

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo‐controlled, phase III trials

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 4, 2015-10 ,pp. : 949-961

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Janus Face of Macrophages in Immunity

By  

Journal of Innate Immunity, Vol. 6, Iss. 6, 2014-09 ,pp. : 713-715

Karger

Access to resources Recommend Favorite